Home » BIONICHE LIFE SCIENCES ISSUES RECALL OF BETAC
BIONICHE LIFE SCIENCES ISSUES RECALL OF BETAC
Bioniche Life Sciences, a research-based, technology-driven Canadian biopharmaceutical company, today announced that the Canadian arm of its Pharma Division (Bioniche Pharma Canada Limited) is initiating a Class 1 recall of Betac, (NDC 62086-139-50/DIN 02245625), an injectable ascorbic acid product that is produced at the Bioniche Pharma Group Limited's sterile injectable manufacturing facility in Galway, Ireland. Approximately one-third of the product released to the market has been found to contain visible particulate matter (microbial in origin) which could potentially result in serious adverse health reactions.
BioSpace (http://www.biospace.com/news_story.cfm?StoryID=20395020&full=1)
KEYWORDS Daily International Pharma Alert
Upcoming Events
-
21Oct